Drug Shortage Report for NUCYNTA IR
Report ID | 110383 |
Drug Identification Number | 02378280 |
Brand name | NUCYNTA IR |
Common or Proper name | Tapentadol |
Company Name | ENDO VENTURES LTD. |
Market Status | MARKETED |
Active Ingredient(s) | TAPENTADOL |
Strength(s) | 75MG |
Dosage form(s) | TABLET (IMMEDIATE RELEASE) |
Route of administration | ORAL |
Packaging size | 100 tabs |
ATC code | N02AX |
ATC description | OPIOIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-04-01 |
Actual start date | |
Estimated end date | 2020-04-30 |
Actual end date | 2020-04-15 |
Shortage status | Resolved |
Updated date | 2020-04-16 |
Company comments | Limited Inventory available on allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-04-01 | English | Compare |
v2 | 2020-04-01 | French | Compare |
v3 | 2020-04-02 | English | Compare |
v4 | 2020-04-15 | English | Compare |
v5 | 2020-04-15 | French | Compare |
v6 | 2020-04-16 | English | Compare |
Showing 1 to 6 of 6